Protecting against Clostridium difficile illness
Open Access
- 26 April 2005
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 172 (9) , 1178
- https://doi.org/10.1503/cmaj.045336
Abstract
Background and epidemiology: A gram-positive, anaerobic bacterium that is common in the environment, Clostridium difficile is transmitted by the fecal– oral route. Its resistant spores are ingested, survive passage through the stomach and ultimately reside in the colon.[1][1] Antimicrobial therapyKeywords
This publication has 4 references indexed in Scilit:
- Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severityCMAJ : Canadian Medical Association Journal, 2004
- Clostridium difficile-associated diarrhea in adultsCMAJ : Canadian Medical Association Journal, 2004
- Hospitals battling outbreaks of C. difficileCMAJ : Canadian Medical Association Journal, 2004
- Active and passive immunization against Clostridium difficile diarrhea and colitisVaccine, 2003